QNCX
Price
$0.15
Change
-$0.01 (-6.25%)
Updated
Feb 5, 03:41 PM (EDT)
Capitalization
8.85M
26 days until earnings call
Intraday BUY SELL Signals
SLNO
Price
$40.54
Change
-$1.58 (-3.75%)
Updated
Feb 5, 03:48 PM (EDT)
Capitalization
2.26B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

QNCX vs SLNO

Header iconQNCX vs SLNO Comparison
Open Charts QNCX vs SLNOBanner chart's image
Quince Therapeutics
Price$0.15
Change-$0.01 (-6.25%)
Volume$300
Capitalization8.85M
Soleno Therapeutics
Price$40.54
Change-$1.58 (-3.75%)
Volume$430
Capitalization2.26B
QNCX vs SLNO Comparison Chart in %
QNCX
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
QNCX vs. SLNO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNCX is a Hold and SLNO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (QNCX: $0.16 vs. SLNO: $42.12)
Brand notoriety: QNCX and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QNCX: 189% vs. SLNO: 121%
Market capitalization -- QNCX: $8.85M vs. SLNO: $2.26B
QNCX [@Biotechnology] is valued at $8.85M. SLNO’s [@Biotechnology] market capitalization is $2.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNCX’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • QNCX’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both QNCX and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNCX’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • QNCX’s TA Score: 4 bullish, 6 bearish.
  • SLNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than QNCX.

Price Growth

QNCX (@Biotechnology) experienced а -95.00% price change this week, while SLNO (@Biotechnology) price change was +1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

QNCX is expected to report earnings on Mar 03, 2026.

SLNO is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.26B) has a higher market cap than QNCX($8.85M). SLNO YTD gains are higher at: -9.028 vs. QNCX (-95.257). QNCX has higher annual earnings (EBITDA): -44.18M vs. SLNO (-72.08M). SLNO has more cash in the bank: 499M vs. QNCX (26.3M). QNCX has less debt than SLNO: QNCX (18M) vs SLNO (52.7M). SLNO has higher revenues than QNCX: SLNO (98.7M) vs QNCX (0).
QNCXSLNOQNCX / SLNO
Capitalization8.85M2.26B0%
EBITDA-44.18M-72.08M61%
Gain YTD-95.257-9.0281,055%
P/E RatioN/AN/A-
Revenue098.7M-
Total Cash26.3M499M5%
Total Debt18M52.7M34%
FUNDAMENTALS RATINGS
QNCX vs SLNO: Fundamental Ratings
QNCX
SLNO
OUTLOOK RATING
1..100
675
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9980
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLNO's Valuation (38) in the Medical Specialties industry is in the same range as QNCX (47) in the Biotechnology industry. This means that SLNO’s stock grew similarly to QNCX’s over the last 12 months.

SLNO's Profit vs Risk Rating (85) in the Medical Specialties industry is in the same range as QNCX (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to QNCX’s over the last 12 months.

SLNO's SMR Rating (96) in the Medical Specialties industry is in the same range as QNCX (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to QNCX’s over the last 12 months.

SLNO's Price Growth Rating (80) in the Medical Specialties industry is in the same range as QNCX (99) in the Biotechnology industry. This means that SLNO’s stock grew similarly to QNCX’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as QNCX (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to QNCX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNCXSLNO
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
86%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
QNCX
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VPG53.901.08
+2.04%
Vishay Precision Group
ES68.24-0.30
-0.44%
Eversource Energy
FRPT69.20-0.69
-0.99%
Freshpet
ARBE1.11-0.06
-5.13%
Arbe Robotics Ltd
MKDW2.38-0.52
-17.93%
MKDWELL Tech Inc.

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with MREO. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+9.28%
MREO - QNCX
86%
Closely correlated
-2.73%
CALC - QNCX
85%
Closely correlated
+8.37%
TPST - QNCX
84%
Closely correlated
-1.24%
RZLT - QNCX
83%
Closely correlated
-7.62%
GNTA - QNCX
83%
Closely correlated
-1.27%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with MREO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-4.23%
MREO - SLNO
56%
Loosely correlated
-2.73%
AVXL - SLNO
52%
Loosely correlated
-5.92%
KRRO - SLNO
52%
Loosely correlated
-3.46%
ZLAB - SLNO
51%
Loosely correlated
+3.47%
QNCX - SLNO
51%
Loosely correlated
+9.28%
More